查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1519347

2024-2032 年按类型、技术、应用、最终用户和地区分類的放射肿瘤学市场报告

Radiation Oncology Market Report by Type, Technology, Application, End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 144 Pages | 商品交期: 2-3个工作天内

价格

IMARC Group年，全球放射肿瘤市场规模达81亿美元。技术进步、癌症发病率上升、对肿瘤放射的认识不断提高、政府倡议和合作、新疗法的监管批准以及个人化医疗的趋势是促进市场成长的一些因素。

放射肿瘤学市场分析：

主要市场驱动因素：放射肿瘤学市场的成长受到多种因素的推动，包括全球癌症盛行率的飙升。对有效和准确治疗方法的高需求促进了影像导引放射治疗和质子治疗的发展，这进一步刺激了市场成长。另一个趋势是统计上更容易患癌症的老年人口数量的增加。此外，对医疗中心发展的投资，特别是在发展中国家，以及政府和私人癌症筛检和预防措施的可用性正在推动放射肿瘤学市场份额的成长。同时，研究机构和公司正积极联手开发创新放射疗法，这有利于市场成长。

主要市场趋势：放射肿瘤学市场的主要趋势之一是转向大分割和超大分割治疗，即在几次疗程中给予更高剂量的放射。这种方式方便了患者，减少了医疗支出。此外，人工智慧(AI) 和机器学习(ML) 在治疗计划系统中的使用越来越多，产生了更量身定制的管理模式，比传统系统更精确地将辐射传送到受影响的位置，同时减少对周围健康组织的损害，这加速市场成长。此外，多模式治疗持续带来好处，将放射治疗与手术、化疗和免疫疗法等其他治疗方法结合，进一步改善治疗效果。除此之外，将治疗对患者生活品质的影响降至最低的治疗安排的日益增长的趋势正在推动放射肿瘤学市场的成长。

地理趋势：目前，北美处于世界放射肿瘤市场的前沿。有几个因素促成了该地区的主导地位，包括先进的医疗基础设施、高额医疗支出以及知名设备製造商的存在。该地区强大的市场地位也源于积极开展的研究以及质子治疗中心等新技术的高采用率。此外，欧洲市场的扩张是由严格的医疗政策和大规模的公共卫生计划推动的，这些政策和计划强调癌症治疗品质和可近性的重要性。根据放射肿瘤学市场分析，亚太地区是一个新兴地区。医疗保健支出不断增加，癌症意识不断增强。中国和印度等国家的医疗保健设施越来越先进。

竞争格局：市场竞争格局的特征是主要放射肿瘤科公司的存在，例如 Accuray Incorporated、Becton Dickinson and Company、Canon Inc.、Elekta、Hitachi Ltd.、Icad Inc.、Ion Beam Applications、Isoray Inc. .、Mevion Medical Systems Inc.、Nordion (Canada) Inc. (Sotera Health)、P-Cure Ltd.、Varian Medical Systems Inc. (Siemens Healthineers AG)、ViewRay 等。

挑战与机会：放射肿瘤学市场面临挑战，例如与先进放射治疗系统相关的高成本，这可能限制较不富裕地区的市场渗透。监管障碍也带来了重大挑战，因为获得新技术的批准可能既耗时又昂贵。此外，新兴市场缺乏熟练的专业人员，这阻碍了先进疗法的采用。然而，这些挑战也蕴藏着机会。例如，开发具有成本效益的放射治疗机可以帮助渗透低收入市场。针对肿瘤照护人员的教育措施和培训计画可以缓解合格专业人员的短缺问题。

放射肿瘤学市场趋势：

技术进步

影响全球放射肿瘤学市场的主要因素之一是不断进步的技术。技术发展，包括调强放射治疗 (IMRT) 和影像导引放射治疗 (IGRT) 的创建，重新定义了癌症治疗，能够更准确地靶向肿瘤，同时对其他健康细胞的损害最小。例如，IMRT 在其施用的辐射剂量中采用不同强度。该技术使肿瘤科医师能够根据肿瘤的复杂形状调整放射束，同时将对周围健康组织的损害降至最低。另一方面，IGRT 在每次治疗前利用 CT 扫描或 MRI 等专门影像来确定肿瘤的确切位置。除了产生高品质的肿瘤影像外，IGRT 还提供测试位置验证和执行多个机械化放射束的治疗。此外，横向治疗的进步导致了质子治疗的发明。该疗法使用高能量质子而不是传统的 X 射线进行放射，从而实现更高的剂量浓度和最小的副作用。例如，2024年，一个主要来自核武相关科研机构的中国研究小组设计了一个名为Flash的强大辐照系统。该系统能够进行超高能量辐射，并有可能改变传统放射治疗。

癌症发生率上升

全球放射肿瘤学市场主要是由世界各地（主要是发展中国家）癌症发生率的增加所推动的。根据世界卫生组织 (WHO) 关于全球癌症发病的最新报告，2022 年印度新增癌症病例超过 141 万人，癌症相关死亡人数超过 91 万人。率的衡量标准，占所有新兴疾病的十分之一以上。随着年龄的增长，癌症的盛行率会上升；此外，已知机会的变化和长期存在的环境的存在也是额外的成长因素。癌症患者数量的不断增加也推动了放射肿瘤学的需求，预计癌症将成为国际上最常见的死亡原因之一。

提高意识和政府倡议

人们对早期癌症诊断和治疗重要性的认识不断提高，以及公共部门为确保癌症患者获得高品质护理而采取的主动行动和资源分配，正在推动全球放射肿瘤学的发展。多个非政府组织 (NGO) 和国际组织正在实施多项公众意识计划和活动，以提高患者对癌症和日益增长的放射治疗服务需求的认识。政府卫生机构还在癌症控制、设施开发和支付计划方面进行投资，以提高获得放射服务的机会并减轻癌症负担，这进一步推动了放射肿瘤学市场前景。

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球放射肿瘤学市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：按类型

  • 外束放射治疗
    • 市场走向
    • 关键环节
      • 直线加速器
      • 紧凑型先进放射治疗系统
      • 质子治疗
    • 市场预测
  • 内束放射治疗
    • 市场走向
    • 关键环节
      • 近距离放射治疗
      • 全身束放射治疗
      • 其他的
    • 市场预测

第 7 章：市场区隔：依技术

  • 影像导引放射治疗 (IGRT)
    • 市场走向
    • 市场预测
  • 调强放射治疗 (IMRT)
    • 市场走向
    • 市场预测
  • 立体定位技术
    • 市场走向
    • 市场预测
  • 质子束治疗
    • 市场走向
    • 市场预测
  • 3D 适形放射治疗 (3D CRT)
    • 市场走向
    • 市场预测
  • 容积调製电弧疗法 (VMAT)
    • 市场走向
    • 市场预测
  • 近距离放射治疗
    • 市场走向
    • 市场预测

第 8 章：市场区隔：按应用

  • 摄护腺癌
    • 市场走向
    • 市场预测
  • 乳癌
    • 市场走向
    • 市场预测
  • 肺癌
    • 市场走向
    • 市场预测
  • 头颈癌
    • 市场走向
    • 市场预测
  • 大肠直肠癌
    • 市场走向
    • 市场预测
  • 妇科癌症
    • 市场走向
    • 市场预测
  • 子宫颈癌
    • 市场走向
    • 市场预测
  • 阴茎癌
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 9 章：市场区隔：按最终用户

  • 医院
    • 市场走向
    • 市场预测
  • 癌症研究机构
    • 市场走向
    • 市场预测
  • 门诊及放射治疗中心
    • 市场走向
    • 市场预测

第 10 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场走向
    • 市场细分：按国家/地区
    • 市场预测

第 11 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 12 章：价值链分析

第 13 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 14 章：价格分析

第15章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Accuray Incorporated
    • Becton Dickinson and Company
    • Canon Inc.
    • Elekta
    • Hitachi Ltd.
    • Icad Inc.
    • Ion Beam Applications
    • Isoray Inc.
    • Mevion Medical Systems Inc.
    • Nordion (Canada) Inc. (Sotera Health)
    • P-Cure Ltd.
    • Varian Medical Systems Inc. (Siemens Healthineers AG)
    • ViewRay
Product Code: SR112024A5805

The global radiation oncology market size reached US$ 8.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 14.5 Billion by 2032, exhibiting a growth rate (CAGR) of 6.5% during 2024-2032. Technological advancements, rising cancer incidence, increasing awareness regarding oncology radiation, government initiatives, and collaborations, regulatory approvals for new therapies, and the trend towards personalized medicine are some of the factors fostering the market growth.

Radiation Oncology Market Analysis:

Major Market Drivers: The radiation oncology market growth is fueled by the factors, including the surging prevalence of cancer across the globe. The high demand for effective and accurate treatment methods prompts the development of image-guided radiation therapy and proton therapy, which is further stimulating the market growth. Another trend is also the rise in the number of geriatric population that is statistically more prone to cancer. In addition, investments in the development of medical centers, especially in developing countries, and availability of government and private cancer screening and prevention initiatives are driving the radiation oncology market share. In line with this, research institutions and companies are actively joining forces for the development of innovative radiation therapies, which is favoring the market growth.

Key Market Trends: One of the key radiation oncology market trends is the shift toward hypofractionated and ultra-hypofractionated therapies, in which higher doses of radiation are given over few sessions. This approach is convenient for patients and reduces medical expenditures. Moreover, the use of artificial intelligence (AI) and machine learning (ML) in treatment planning systems is growing, producing more tailored administration patterns which deliver radiation more precisely to the affected location than traditional systems while reducing damage to surrounding healthy tissue, which is accelerating the market growth. Furthermore, multimodality treatments continue to provide a boon, combining radiation therapy with other treatments like surgery, chemotherapy, and immunotherapy, which further improves therapeutic outcomes. Apart from this, the growing trend towards therapeutic scheduling that minimizes the impact of the therapy on the patient's quality of life is driving the radiation oncology market growth.

Geographical Trends: At present, North America is at the forefront of the world's radiation oncology market. Several factors contribute to this region's dominance, including the advanced healthcare infrastructure, high healthcare spending, and the presence of prominent device manufacturers. The region's strong market position also stems from research being pursued aggressively and high rates of new technology adoption, such as proton therapy centers. Moreover, Europe's market expansion is driven by stringent healthcare policies and large-scale public health programs that stress the importance of cancer treatment quality and accessibility. As per the radiation oncology market analysis, the Asia-Pacific is an up-and-coming region. Healthcare spending is on the rise, and cancer awareness is growing. The healthcare facilities are becoming more advanced in countries such as China and India.

Competitive Landscape: The competitive landscape of the market is characterized by the presence of key radiation oncology companies, such as Accuray Incorporated, Becton Dickinson and Company, Canon Inc., Elekta, Hitachi Ltd., Icad Inc., Ion Beam Applications, Isoray Inc., Mevion Medical Systems Inc., Nordion (Canada) Inc. (Sotera Health), P-Cure Ltd., Varian Medical Systems Inc. (Siemens Healthineers AG), ViewRay, etc.

Challenges and Opportunities: The radiation oncology market faces challenges such as high costs associated with advanced radiation therapy systems, which can limit market penetration in less affluent regions. Regulatory hurdles also pose significant challenges, as gaining approval for new technologies can be time-consuming and costly. Moreover, there is a shortage of skilled professionals in emerging markets, which hampers the adoption of advanced therapies. However, these challenges also present opportunities. For example, the development of cost-effective radiation therapy machines can help penetrate low-income markets. Educational initiatives and training programs for oncology care providers can alleviate the shortage of qualified professionals.

Radiation Oncology Market Trends:

Technological Advancements

One of the major factors influencing the global radiation oncology market is the continually advancing technology. Technological development, including the creation of intensity modulated radiation therapy (IMRT) and image-guided radiation therapy (IGRT), have redefined the treatment of cancer, enabling more accurate targeting of tumors with minimal damage to other healthy body cells. For example, IMRT employs varied intensities in the radiation doses it administers. This technology enables oncologists to conform the radiation beams according to the complicated shape of the tumor with minimal destruction of surrounding healthy tissues. IGRT, on the other hand, utilizes specialized imagining such as CT scans or MRIs to identify the tumor's exact location before each treatment session. In addition to producing high quality images of the tumor, IGRT offers test position verification and treatment carrying out several mechanized radiation beams. Further, lateral therapy advancements have resulted in the invention of proton therapy. This therapy administers radiation with high-energy protons instead of traditional x-rays, allowing superior dose concentration with minimal side effects. For instance, in 2024, a powerful irradiation system called the Flash was designed by a Chinese research group mainly from nuclear weapons related scientific institutions. The system is capable of administering ultra-high energy radiation and has the potential to transform conventional radiotherapy.

Rising Incidence of Cancer

The global radiation oncology market is primarily fueled by an increase in cancer occurrence across the world, mainly in developing countries. According to the most recent report on the global occurrence of the disease by the World Health Organization (WHO), there were over 14.1 lakh new cancer instances and more than 9.1 lakh cancer-related deaths in India in 2022. Breast cancer was the most frequently identified measure of global occurrence of the disease, accounting for more than one-tenth of all new illnesses. The prevalence of cancer rises as people age; moreover, a change in long-known chances and the presence of longstanding environmental are additional growth factors. The radiation oncology demand is also boosted by the growing number of cancer patients, which is predicted to be one of the most common causes of death internationally.

Increasing Awareness and Government Initiatives

Rising knowledge about the importance of early cancer diagnosis and treatment, as well as public sector proactiveness and allocation of resources to ensure that cancer patients receive high-quality care, are driving the growth of radiation oncology globally. Several public awareness programs and campaigns are being implemented by various non-governmental organizations (NGOs) and international organizations to boost patient awareness of cancer and the rising need for radiation therapy services. Government health agencies are also investing in cancer control, facilities development, and payment schemes to enhance access to radiation services and reduce the cancer burden, which is further driving the radiation oncology market outlook.

Radiation Oncology Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on the type, technology, application, and end user.

Breakup by Type:

External Beam Radiation Therapy

Linear Accelerators

Compact Advanced Radiotherapy Systems

Proton Therapy

Internal Beam Radiation Therapy

Brachytherapy

Systemic Beam Radiation Therapy

Others

External beam radiation therapy (EBRT) accounts for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the type. This includes external beam radiation therapy (linear accelerators, compact advanced radiotherapy systems, proton therapy) and internal beam radiation therapy (brachytherapy, systemic beam radiation therapy, and others). According to the report, external beam radiation therapy (EBRT) represented the largest segment.

Breakup by Technology:

Image-Guided Radiotherapy (IGRT)

Intensity Modulated Radiotherapy (IMRT)

Stereotactic Technology

Proton Beam Therapy

3D Conformal Radiotherapy (3D CRT)

Volumetric Modulated Arc Therapy (VMAT)

Brachytherapy

The report has provided a detailed breakup and analysis of the market based on the technology. This includes image-guided radiotherapy (IGRT), intensity modulated radiotherapy (IMRT), stereotactic technology, proton beam therapy, 3D conformal radiotherapy (3D CRT), volumetric modulated arc therapy (VMAT), and brachytherapy.

Breakup by Application:

Prostate Cancer

Breast Cancer

Lung Cancer

Head and Neck Cancer

Colorectal Cancer

Gynecological Cancer

Cervical Cancer

Penile Cancer

Others

The report has provided a detailed breakup and analysis of the market based on the application. This includes prostate cancer, breast cancer, lung cancer, head and neck cancer, colorectal cancer, gynecological cancer, cervical cancer, penile cancer, and others.

Breakup by End User:

Hospitals

Cancer Research Institutes

Ambulatory and Radiotherapy Centers

The report has provided a detailed breakup and analysis of the market based on the end user. This includes hospitals, cancer research institutes, and ambulatory and radiotherapy centers.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America leads the market, accounting for the largest radiation oncology market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

Key Questions Answered in This Report:

  • How has the global radiation oncology market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global radiation oncology market?
  • What is the impact of each driver, restraint, and opportunity on the global radiation oncology market?
  • What are the key regional markets?
  • Which countries represent the most attractive radiation oncology market?
  • What is the breakup of the market based on the type?
  • Which is the most attractive type in the radiation oncology market?
  • What is the breakup of the market based on technology?
  • Which is the most attractive technology in the radiation oncology market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the radiation oncology market?
  • What is the breakup of the market based on the end-user?
  • Which is the most attractive end-user in the radiation oncology market?
  • What is the competitive structure of the market?
  • Who are the key players/companies in the global radiation oncology market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Radiation Oncology Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 External Beam Radiation Therapy
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Linear Accelerators
      • 6.1.2.2 Compact Advanced Radiotherapy Systems
      • 6.1.2.3 Proton Therapy
    • 6.1.3 Market Forecast
  • 6.2 Internal Beam Radiation Therapy
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Brachytherapy
      • 6.2.2.2 Systemic Beam Radiation Therapy
      • 6.2.2.3 Others
    • 6.2.3 Market Forecast

7 Market Breakup by Technology

  • 7.1 Image-Guided Radiotherapy (IGRT)
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Intensity Modulated Radiotherapy (IMRT)
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Stereotactic Technology
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Proton Beam Therapy
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 3D Conformal Radiotherapy (3D CRT)
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Volumetric Modulated Arc Therapy (VMAT)
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast
  • 7.7 Brachytherapy
    • 7.7.1 Market Trends
    • 7.7.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Prostate Cancer
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Breast Cancer
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Lung Cancer
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Head and Neck Cancer
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Colorectal Cancer
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Gynecological Cancer
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast
  • 8.7 Cervical Cancer
    • 8.7.1 Market Trends
    • 8.7.2 Market Forecast
  • 8.8 Penile Cancer
    • 8.8.1 Market Trends
    • 8.8.2 Market Forecast
  • 8.9 Others
    • 8.9.1 Market Trends
    • 8.9.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Cancer Research Institutes
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Ambulatory and Radiotherapy Centers
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Accuray Incorporated
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Becton Dickinson and Company
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Canon Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Elekta
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Hitachi Ltd.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Icad Inc.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Ion Beam Applications
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Isoray Inc.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
    • 15.3.9 Mevion Medical Systems Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
    • 15.3.10 Nordion (Canada) Inc. (Sotera Health)
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 SWOT Analysis
    • 15.3.11 P-Cure Ltd.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
    • 15.3.12 Varian Medical Systems Inc. (Siemens Healthineers AG)
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 SWOT Analysis
    • 15.3.13 ViewRay
      • 15.3.13.1 Company Overview
      • 15.3.13.2 Product Portfolio
      • 15.3.13.3 Financials

List of Figures

  • Figure 1: Global: Radiation Oncology Market: Major Drivers and Challenges
  • Figure 2: Global: Radiation Oncology Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Radiation Oncology Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Radiation Oncology Market: Breakup by Type (in %), 2023
  • Figure 5: Global: Radiation Oncology Market: Breakup by Technology (in %), 2023
  • Figure 6: Global: Radiation Oncology Market: Breakup by Application (in %), 2023
  • Figure 7: Global: Radiation Oncology Market: Breakup by End User (in %), 2023
  • Figure 8: Global: Radiation Oncology Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Radiation Oncology (External Beam Radiation Therapy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Radiation Oncology (External Beam Radiation Therapy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Radiation Oncology (Internal Beam Radiation Therapy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Radiation Oncology (Internal Beam Radiation Therapy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Radiation Oncology (Image-Guided Radiotherapy (IGRT)) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Radiation Oncology (Image-Guided Radiotherapy (IGRT)) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Radiation Oncology (Intensity Modulated Radiotherapy (IMRT)) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Radiation Oncology (Intensity Modulated Radiotherapy (IMRT)) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Radiation Oncology (Stereotactic Technology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Radiation Oncology (Stereotactic Technology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Radiation Oncology (Proton Beam Therapy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Radiation Oncology (Proton Beam Therapy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Radiation Oncology (3D Conformal Radiotherapy (3D CRT)) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Radiation Oncology (3D Conformal Radiotherapy (3D CRT)) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Radiation Oncology (Volumetric Modulated Arc Therapy (VMAT)) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Radiation Oncology (Volumetric Modulated Arc Therapy (VMAT)) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Radiation Oncology (Brachytherapy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Radiation Oncology (Brachytherapy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Radiation Oncology (Prostate Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Radiation Oncology (Prostate Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Radiation Oncology (Breast Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Radiation Oncology (Breast Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Radiation Oncology (Lung Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Radiation Oncology (Lung Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Radiation Oncology (Head and Neck Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Radiation Oncology (Head and Neck Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Radiation Oncology (Colorectal Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Radiation Oncology (Colorectal Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Global: Radiation Oncology (Gynecological Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Global: Radiation Oncology (Gynecological Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Global: Radiation Oncology (Cervical Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Global: Radiation Oncology (Cervical Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Global: Radiation Oncology (Penile Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Global: Radiation Oncology (Penile Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Global: Radiation Oncology (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Global: Radiation Oncology (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Global: Radiation Oncology (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Global: Radiation Oncology (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Global: Radiation Oncology (Cancer Research Institutes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Global: Radiation Oncology (Cancer Research Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Global: Radiation Oncology (Ambulatory and Radiotherapy Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Global: Radiation Oncology (Ambulatory and Radiotherapy Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: North America: Radiation Oncology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: North America: Radiation Oncology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: United States: Radiation Oncology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: United States: Radiation Oncology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Canada: Radiation Oncology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Canada: Radiation Oncology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Asia-Pacific: Radiation Oncology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Asia-Pacific: Radiation Oncology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: China: Radiation Oncology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: China: Radiation Oncology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Japan: Radiation Oncology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Japan: Radiation Oncology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: India: Radiation Oncology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: India: Radiation Oncology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: South Korea: Radiation Oncology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: South Korea: Radiation Oncology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Australia: Radiation Oncology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Australia: Radiation Oncology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Indonesia: Radiation Oncology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Indonesia: Radiation Oncology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Others: Radiation Oncology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Others: Radiation Oncology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Europe: Radiation Oncology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Europe: Radiation Oncology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Germany: Radiation Oncology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Germany: Radiation Oncology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: France: Radiation Oncology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: France: Radiation Oncology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: United Kingdom: Radiation Oncology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: United Kingdom: Radiation Oncology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Italy: Radiation Oncology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: Italy: Radiation Oncology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Spain: Radiation Oncology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 84: Spain: Radiation Oncology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 85: Russia: Radiation Oncology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 86: Russia: Radiation Oncology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 87: Others: Radiation Oncology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 88: Others: Radiation Oncology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 89: Latin America: Radiation Oncology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 90: Latin America: Radiation Oncology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 91: Brazil: Radiation Oncology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 92: Brazil: Radiation Oncology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 93: Mexico: Radiation Oncology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 94: Mexico: Radiation Oncology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 95: Others: Radiation Oncology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 96: Others: Radiation Oncology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 97: Middle East and Africa: Radiation Oncology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 98: Middle East and Africa: Radiation Oncology Market: Breakup by Country (in %), 2023
  • Figure 99: Middle East and Africa: Radiation Oncology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 100: Global: Radiation Oncology Industry: SWOT Analysis
  • Figure 101: Global: Radiation Oncology Industry: Value Chain Analysis
  • Figure 102: Global: Radiation Oncology Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Radiation Oncology Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Radiation Oncology Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 3: Global: Radiation Oncology Market Forecast: Breakup by Technology (in Million US$), 2024-2032
  • Table 4: Global: Radiation Oncology Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 5: Global: Radiation Oncology Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 6: Global: Radiation Oncology Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Radiation Oncology Market: Competitive Structure
  • Table 8: Global: Radiation Oncology Market: Key Players